Cencora

Last updated

Cencora, Inc.
FormerlyAmerisourceBergen Corporation (2001–2023)
Company type Public company
Industry Pharmaceutical
Founded2001;23 years ago (2001) (merger between AmeriSource Health and Bergen Brunswig)
Headquarters Conshohocken, Pennsylvania, U.S.
Area served
Key people
Richard C. Gozon
(Chairman)
Steven H. Collis
(President & CEO)
Products Pharmaceuticals and pharmacy services
RevenueIncrease2.svg US$238.6 billion (2022)
Increase2.svgUS$2.37 billion (2022)
Increase2.svgUS$1.70 billion (2022)
Total assets Decrease2.svgUS$56.56 billion (2022)
Total equity Decrease2.svgUS$71.27 million (2022)
Owner Walgreens Boots Alliance (25%)
Number of employees
c. 44,000 (2022)
Website cencora.com
Footnotes /references
Financials as of September 30,2022 [1]

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]

Contents

Services

They provide drug distribution and consulting related to medical business operations and patient services. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to health care providers throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers' compensation and specialty drug patients.

AmerisourceBergen handles about 20% of all of the pharmaceuticals sold and distributed throughout the United States and ranked 10th on the Fortune 500 list for 2020 with over $179 billion in annual revenue. [3]

History

AmerisourceBergen was formed in 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. [4] David Yost was CEO of Amerisource prior to the merger and remained in the position after the companies merged. [5]

AmerisourceBergen has 26 pharmaceutical distribution centers in the US, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production capacity in the US and the UK. With the addition of World Courier, [6] the largest specialty courier company in the world, over 150 company-owned offices around the globe were added to the company.

AmerisourceBergen operates its pharmaceutical distribution business under four primary units: AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS) and World Courier. In March 2016 Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company. [7]

In 2012, the firm was the largest by revenue based in Pennsylvania. [8] [9]

The company has announced its intention to change its name to Cencora, effective in mid-2023. [10]

Good Neighbor Pharmacy

Good Neighbor Pharmacy is an American retailers' cooperative network of more than 3,400 independently owned and operated pharmacies. It has a business affiliation with AmerisourceBergen, which sponsors the network and owns the name "Good Neighbor Pharmacy." Good Neighbor Pharmacy is the sponsor for "Thought Spot" the annual trade show held in Las Vegas.

Acquisitions

In June 2020, the U.S. Department of Health and Human Services (HHS) announced an unusual agreement for the distribution of remdesivir, the first coronavirus drug. HHS agreed to manufacturer Gilead's wholesale acquisition price, while HHS would continue to work together with state governments and AmerisourceBergen to allocate shipments of remdesivir vials to American hospitals through the end of September 2020, and in exchange, during that time-frame American patients would be allocated over 90% of Gilead's projected remdesivir output of more than 500,000 treatment courses. [18] [19]

Finances

For the fiscal year 2019, AmerisourceBergen reported earnings of US$1.11 billion, with an annual revenue of US$179.58 billion. AmerisourceBergen's shares traded at over $88 per share, and its market capitalization was valued at over US$19.2 billion in September 2019. [20]

Controversies

Opioid epidemic

AmerisourceBergen is among several distributors that have been sued by West Virginian governments for contributing to the Opioid epidemic, by shipping inordinate amounts of pain medication into the state. [21] [22] [23]

In December 2019, Michigan became the first state to sue AmerisourceBergen and three other opioid distributors as drug dealers for their role in the state's opioid crisis. [24] [25] The lawsuit is filed under the Michigan Drug Dealer Liability Act. [26] AmerisourceBergen was among four companies who, because of their role in the addiction crisis, agreed to pay $260 million to two Ohio counties. [27]

In May 2020, Oklahoma Attorney General Mike Hunter sued AmerisourceBergen in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets." [28]

In January 2022, AmerisourceBergen, McKesson, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them. [29] Had the states gone to court, the companies could have faced up to $95 billion in penalties. [30]

On October 1 2018, Amerisourcebergen agreed to pay $625M to resolve allegations that it had illegally repackaged and distributed oncology-supportive injectable drugs. [31]

In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks to physicians. [32]

As part of the civil settlement, ABC admitted that between January 2001 and January 2014, MII and OSC operated a program that created, packed and shipped millions of PFS to oncology practices for administration to vulnerable cancer patients (the PFS Program).  At MII, an ABC subsidiary located in Alabama, the drug product was removed from the original glass vials and multiple vials of the product were pooled in untested plastic containers.  Then the drug, including the overfill, was extracted and repackaged into syringes.  By harvesting the overfill, ABC was able to create more doses than it bought from the original vial manufacturers and avoid opening some of the vials.  ABC retained the unopened vials and sold them to other customers and to its subsidiary ABDC for resale.  During the 13 years the PFS Program was in operation, MII manufactured thousands of syringes daily, and eventually over one million syringes per year.  These syringes were sold throughout the United States.  Approximately 57% of the patients who were injected with the PFS were Federal Health Care Program beneficiaries.  The profit from the PFS Program was between $2.3 and $14.4 million annually for a total profit of at least $99.6 million. [32]

ABC’s scheme enabled it to bill multiple health care providers for the same vial of drug, causing some of those providers to bill the Federal Health Care Programs for the same vial more than once.  The scheme also enabled ABC to increase its market share by offering various product discounts, which it leveraged to obtain new customers and to keep existing customers who purchased its entire portfolio of oncology drugs.  ABC excluded the entire PFS Program from its standard regulatory audit and pedigree compliance programs. [32] [33] AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. [34] [35] States countered with $45 billion. [36]

Related Research Articles

<span class="mw-page-title-main">CVS Pharmacy</span> American pharmacy chain

CVS Pharmacy, Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts in 1963.

Walgreens is an American company that operates the second-largest pharmacy store chain in the United States, behind CVS Health. It specializes in filling prescriptions, health and wellness products, health information, and photo services. It was founded in Chicago in 1901, and is headquartered in the Chicago suburb of Deerfield, Illinois. On December 31, 2014, Walgreens and Switzerland-based Alliance Boots merged to form a new holding company, Walgreens Boots Alliance. Walgreens became a subsidiary of the new company, which retained its Deerfield headquarters and trades on the Nasdaq under the symbol WBA. In 2021 the company was found by a federal jury to have "substantially contributed to" the opioid crisis.

<span class="mw-page-title-main">Alliance Healthcare</span> European health products distributor

Alliance Healthcare, formerly Alliance UniChem, is a wholesaler, distributer and retailer of pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres, and hospitals from over 288 distribution centres in 11 countries.

McKesson Europe

McKesson Europe AG, with its headquarters in Stuttgart, Germany, is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year and is represented in 13 countries in Europe. In the 2019 financial year the company achieved a turnover of EUR 21.18 billion. The majority shareholder of the company is the US-based McKesson Corporation, which holds a share of 77.01%. The remaining 22.99% of shares are available on the open market. Kevin Kettler, a US citizen, has been Chairman of McKesson Europe since 1 November 2018.

<span class="mw-page-title-main">McKesson Corporation</span> U.S. healthcare company

McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021.

<span class="mw-page-title-main">Cardinal Health</span> American multinational health care services company

Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical products, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.

Drug diversion is a medical and legal concept involving the transfer of any legally prescribed controlled substance from the individual for whom it was prescribed to another person for any illicit use. The definition varies slightly among different jurisdictions, but the transfer of a controlled substance alone usually does not constitute a diversion, since certain controlled substances that are prescribed to a child are intended to be administered by an adult, as directed by a medical professional. The term comes from the "diverting" of the drugs from their original licit medical purpose. In some jurisdictions, drug diversion programs are available to first time offenders of diversion drug laws, which "divert" offenders from the criminal justice system to a program of education and rehabilitation.

<span class="mw-page-title-main">Rite Aid</span> American drugstore chain

Rite Aid Corporation is an American drugstore chain based in Philadelphia, Pennsylvania. It was founded in 1962 in Scranton, Pennsylvania, by Alex Grass under the name Thrift D Discount Center. It is the third-largest drugstore chain in the United States, with over 2,000 stores, and ranked No. 148 in the Fortune 500 in 2022.

Longs Drugs is an American chain owned by parent company CVS Health with approximately 70 drugstores throughout the state of Hawaii and formerly in the Continental US.

The Katz Group of Companies is a Canadian privately-owned enterprise, with operations in sports and entertainment and real estate development. Oilers Entertainment Group (OEG), a subsidiary of the Katz Group, owns the National Hockey League five-time Stanley Cup Champion Edmonton Oilers, as well as professional hockey franchises in the American Hockey League, Western Hockey League, and ECHL, and Aquila Productions, an entertainment and event company. OEG operates Rogers Place in downtown Edmonton. Katz Group is also involved in land assembly, site, and building development in Canada and the United States, including the design and development of Ice District, an area encompasses more than 25 acres anchored by Rogers Place. Katz Group is based in Edmonton, Alberta. Its founder and chairman is Daryl Katz.

PharMerica is a Fortune 1000 company formed in January 2007 from the merger of Kindred Healthcare's pharmacy business with a subsidiary of AmerisourceBergen.

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's largest healthcare company, and its headquarters are in Woonsocket, Rhode Island.

<span class="mw-page-title-main">Mallinckrodt</span> Irish domiciled pharmaceutical

Mallinckrodt Pharmaceuticals is an American-Irish domiciled manufacturer of specialty pharmaceuticals, generic drugs and imaging agents. In 2017, it generated 90% of its sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversion to Ireland drew controversy when it was shown Acthar was Medicaid's most expensive drug.

<span class="mw-page-title-main">W. Mark Lanier</span> American lawyer

William Mark Lanier is an American trial lawyer and founder and CEO of the Lanier Law Firm. He has led a number of high profile product litigation suits resulting in billions of dollars in damages, including Johnson & Johnson baby powder and Merck & Co.'s Vioxx drug.

Gregory David Wasson is an American businessman. He is the co-founder and president of Wasson Enterprise, a family-based investment office, the executive chairman of Innventure, co-founder of CoolerScreens, and the former president and chief executive officer (CEO) of Walgreens Boots Alliance (NASDAQ:WBA).

<span class="mw-page-title-main">Ornella Barra</span> Italian-born Monegasque businesswoman

Ornella Barra is an Italian-born Monegasque businesswoman. A qualified pharmacist, she is chief operating officer, international of Walgreens Boots Alliance. She is married to the Italian billionaire Stefano Pessina.

Walgreens Boots Alliance, Inc. (WBA) is an American multinational holding company headquartered in Deerfield, Illinois, which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies. The company was formed on December 31, 2014, after Walgreens purchased the 55% stake in Alliance Boots that it did not already own. The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion. Walgreens had previously purchased 45% of the company for $4.0 billion and 83.4 million common shares in August 2012 with an option to purchase the remaining shares within three years. Walgreens became a subsidiary of the newly created company after the transactions were completed. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings of the largest United States corporations by total revenue.

<span class="mw-page-title-main">Opioid epidemic in the United States</span> Ongoing overuse of opioid medication in the US

In the United States, the opioid epidemic is an extensive, ongoing overuse of opioid medications, both from medical prescriptions and illegal sources. The epidemic began in the United States in the late 1990s, according to the Centers for Disease Control and Prevention (CDC), when opioids were increasingly prescribed for pain management, resulting in a rise in overall opioid use throughout subsequent years. The great majority of Americans who use prescription opioids do not believe that they are misusing them.

<i>The Crime of the Century</i> (2021 film) American documentary film

The Crime of the Century is an American two-part documentary film, directed, produced, and written by Alex Gibney. The film follows the opioid epidemic in the United States, and the political operatives, government regulations and corporations that enable the abuse of opioids, particularly the Sackler family and Purdue Pharma.

DEA-DOJ v. Walmart Inc. was a settlement involving the complaints and lawsuits of Walmart pharmacy, and other large pharmaceutical companies. The lawsuits were made after an official complaint issued by the United States Department of Justice and the Drug Enforcement Administration, after Walmart was accused of illegally selling opioids to their customers, despite prior laws prohibiting such actions.

References

  1. ↑ "US SEC: Form 10-K AmerisourceBergen". United States Securities and Exchange Commission. November 22, 2022.
  2. ↑ "AmerisourceBergen, Form 8-K, Current Report, Filing Date Aug 30, 2001". secdatabase.com. Retrieved January 7, 2013.
  3. ↑ "AmerisourceBergen | 2020 Fortune 500". Fortune. Retrieved January 12, 2021.
  4. ↑ "AmerisourceBergen Added to S&P 500 index". Archived from the original on March 22, 2016. Retrieved July 12, 2017.
  5. 1 2 "UPDATE 2-Amerisource CEO Yost to retire, Collis to succeed". Reuters. March 14, 2011. Retrieved July 17, 2020.
  6. ↑ "AmerisourceBergen Acquires World Courier". World Courier. Retrieved August 16, 2019.
  7. ↑ Leeclaire, George (March 18, 2016). "Walgreens Boots buys bigger stake in AmerisourceBergen". Associated Press. Retrieved September 25, 2016.
  8. ↑ AmerisourceBergen: The biggest Pennsylvania company you never heard of, by David Sell, Philadelphia Inquirer, July 15, 2012
  9. ↑ "Eight area companies make Fortune 500". Philadelphia Business Journal . May 28, 2013. Retrieved June 24, 2013.
  10. ↑ "AmerisourceBergen Announces Intent to Change Name to Cencora". www.businesswire.com. January 24, 2023. Retrieved March 24, 2023.
  11. ↑ "AmerisourceBergen buys IntrinsiQ". Philadelphia Business Journal. September 6, 2011.
  12. ↑ "AmerisourceBergen buys Premier Source". The Oklahoman. September 2, 2011. Archived from the original on July 17, 2020. Retrieved July 17, 2020.
  13. ↑ Sell, David (March 6, 2012). "AmerisourceBergen to acquire World Courier Group". The Philadelphia Inquirer. Retrieved July 17, 2020.
  14. 1 2 "AmerisourceBergen to buy PharMEDium for $2.58 billion". Reuters. October 6, 2015. Retrieved July 17, 2020.
  15. ↑ "AmerisourceBergen Completes Acquisition of HD Smith". AmerisourceBergen. Archived from the original on September 26, 2018. Retrieved September 25, 2018.
  16. ↑ Olsen, Dean. "Former H.D. Smith workforce reducing to 25 locally". The State Journal-Register. Archived from the original on July 17, 2020. Retrieved July 17, 2020.
  17. ↑ "Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen Divesting Alliance Healthcare Businesses". Businesswire (Press release).
  18. ↑ Kolata G (June 29, 2020). "Remdesivir, the First Coronavirus Drug, Gets a Price Tag". The New York Times . Retrieved June 29, 2020.
  19. ↑ "Trump Administration Secures New Supplies of Remdesivir for the United States" (Press release). U.S. Department of Health and Human Services (HHS). June 29, 2020. Archived from the original on June 29, 2020. Retrieved June 29, 2020.
  20. ↑ "Financial Reports | AmerisourceBergen Corporation". AmerisourceBergen Corporation. Retrieved November 7, 2018.
  21. ↑ Higham, Scott; Bernstein, Lenny (March 9, 2017). "Opioid distributors sued by West Virginia counties hit by drug crisis". Washington Post. ISSN   0190-8286 . Retrieved February 13, 2018.
  22. ↑ Jon Kamp (June 27, 2012). "West Virginia Sues Drug Distributors in Pill-Abuse Fight". WSJ. Retrieved January 23, 2016.
  23. ↑ "Drug firms shipped 40M pain pills a year to WV". Charleston Gazette-Mail. May 17, 2015. Retrieved January 23, 2016.
  24. ↑ Herman, Bob (December 18, 2019). "Major health care companies keep getting taken to court". Axios. Retrieved June 25, 2020.
  25. ↑ Rossman-Mckinney, Kelly (December 17, 2019). "Michigan Goes After Opioid Distributors; Files Lawsuit Under Michigan Drug Dealer Liability Act". Michigan Department of the Attorney General.
  26. ↑ "Michigan Legislature - Section 691.1605". www.legislature.mi.gov. Retrieved June 25, 2020.
  27. ↑ Ghose, Carrie (October 21, 2019). "Cardinal Health, McKesson, AmerisourceBergen, Teva agree to $260M opioid settlement with Cuyahoga, Summit counties". Columbus Business First. Retrieved June 25, 2020.
  28. ↑ "Attorney General Hunter Refiles Lawsuits against Three Leading Opioid Distributors | Oklahoma Attorney General". oag.ok.gov. Retrieved March 12, 2022.
  29. ↑ Raymond, Nate (January 27, 2022). "Most U.S. local governments opt to join $26 bln opioid settlement". Reuters. Retrieved February 21, 2022.
  30. ↑ Raymond, Nate (November 16, 2021). "Washington state, in $95 billion opioid trial, blames drug distributors for crisis". Reuters. Retrieved February 21, 2022.
  31. ↑ "AmerisourceBergen Corporation Agrees to Pay $625 Million to Resolve Allegations That it Illegally Repackaged Cancer–Supportive Injectable Drugs to Profit From Overfill". www.justice.gov. October 1, 2018. Retrieved February 22, 2022.
  32. 1 2 3 "AmerisourceBergen Corp. To Pay $625 Million To Settle Civil Fraud Allegations Resulting From Its Repackaging And Sale Of Adulterated Drugs And Unapproved New Drugs, Double Billing And Providing Kickbacks". www.justice.gov. October 1, 2018. Retrieved June 26, 2020.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  33. ↑ "AmerisourceBergen to pay $625M to settle whistleblower case for selling cancer vial overfills". FiercePharma. Retrieved June 26, 2020.
  34. ↑ Herman, Bob. "Wall Street's fear of an opioids settlement". Axios. Retrieved June 26, 2020.
  35. ↑ "Opioid Distributors Propose $10 Billion to End State Claims". Bloomberg.com. August 6, 2019. Retrieved June 26, 2020.
  36. ↑ Herman, Bob. "McKesson, Cardinal, AmerisourceBergen offer $10 billion opioid settlement". Axios. Retrieved June 26, 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.